Skip to main content
Figure 3 | Critical Care

Figure 3

From: The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting

Figure 3

Plasma cystatin-C levels. The time course of plasma cystatin-C levels in patients with myocardial dysfunction after coronary artery bypass grafting surgery, treated with adrenaline (n = 7) or milrinone (n = 11), and in control patients (n = 20) not needing inotropic support. Data are given as mean ± standard error of the mean. aSignificant difference (p < 0.05) in comparison with baseline values (paired t test); bsignificant difference (p < 0.05) in comparison with the control group (analysis of variance [ANOVA] with post hoc Fisher's predicted least-square difference [PLSD]); csignificant difference (p < 0.05) between the adrenaline and the milrinone group (ANOVA with post hoc Fisher's PLSD).

Back to article page

Critical Care

ISSN: 1364-8535